Abstract
Strategies that restore immune tolerance are attracting growing interest in their potential to advance the treatment of type 1 diabetes beyond lifelong insulin therapy. Dan Jones investigates.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Retuning the immune system: the future of type 1 diabetes therapy?. Nat Rev Drug Discov 8, 600–601 (2009). https://doi.org/10.1038/nrd2956
Issue Date:
DOI: https://doi.org/10.1038/nrd2956
- Springer Nature Limited
This article is cited by
-
TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice
Scientific Reports (2015)